van der Heijde, Désirée <br/><br/>
Disease activity, physical function, and radiographic progression after longterm therapy with adalimumab plus methotrexate: 5-year results of PREMIER.  [electronic resource] 

 -  The Journal of rheumatology  Nov 2010 
 - 2237-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1499-2752 
<br/><br/><label>Standard No.: </label>10.3899/jrheum.100208  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--diagnostic imaging<br/>Arthrography<br/>Disease Progression<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Joints--physiopathology<br/>Male<br/>Methotrexate--administration & dosage<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors